Article
DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer
1 May 2023
Abstract excerpt
Increasing evidence indicates that DNA damage-induced apoptosis suppressor (DDIAS) is an oncogenic protein that is highly expressed in a variety of cancers, including colorectal cancer, lung cancer, breast cancer, and hepatocellular carcinoma (HCC). The discovery of DDIAS as a novel therapeutic target and its role in human cancer biology is fascinating and noteworthy. Recent studies have shown that DDIAS is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
